Monkeypox
📧 Sign up to get email alerts when something new happens for Monkeypox.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Observational Mondkeypox Pregnancy Cohort
An observational cohort study examining monkeypox infection during pregnancy. The study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)
This is a clinical trial update for the ProMPX study evaluating the virological, immunological, psychosocial, and epidemiological consequenc…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine [Phase 2]
Phase 2 trial update evaluating immunogenicity of dose-reduction strategies for the MVA-BN Monkeypox vaccine; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years [Phase 2, Phase 3]
Phase 2/3 trial evaluating immunogenicity, reactogenicity, and safety of the VACΔ6 vaccine in adults 18-60; study completed.
-
EMA guidance · 2022-08-19EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox
EMA’s Emergency Task Force recommends intradermal administration of Imvanex/Jynneos for monkeypox to optimize dose use and supply during out…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA guidance · 2022-07-27EMA response to the monkeypox public health emergency
EMA outlines its response and actions in relation to the monkeypox public health emergency, including regulatory considerations and support …
-
EMA approval · 2022-07-22EMA recommends approval of Imvanex for the prevention of monkeypox disease
EMA recommends approval of Imvanex for preventing monkeypox disease, signaling a new preventive indication for the vaccine.
-
EMA guidance · 2022-06-28Monkeypox: EMA starts review for Imvanex
EMA initiates a review of Imvanex in relation to Monkeypox to assess available evidence and potential regulatory actions.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Phase I Trial of an Investigational Small Pox Medication [Phase 1]
Phase I study of SIGA Technologies' investigational smallpox antiviral tecovirimat (ST-246) has completed and posted results.